ConductScience.org, home

Paper2143752

Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.

Baker PJ and 6 others. Infect Immun, 1990. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides. Papers, record 2143752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2143752

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.
PubMed
Journal
Infect Immun
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2021-05-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baker PJP J
2Taylor CEC E
3Stashak PWP W
4Fauntleroy MBM B
5Hasløv KK
6Qureshi NN
7Takayama KK

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Polysaccharides, BacterialMajor topic
Rhodobacter sphaeroidesMajor topic
T-Lymphocytes, RegulatoryMajor topic
Animals
Antibodies, Bacterial
B-Lymphocytes
Female
Immunoglobulin M
Lipid A
Lymphocyte Activation
Mice
Mice, Nude

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-25856NIAID NIH HHSUnited StatesU01AI025856PubMed and NIHNIH RePORTER
GM-36054NIGMS NIH HHSUnited StatesR01GM036054PubMed and NIHNIH RePORTER

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,388,600Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.Appl Microbiol1969https://conductscience.org/library/papers/4388600PubMed
26,355,099Position of ester groups in the lipid A backbone of lipopolysaccharides obtained from Salmonella typhimurium.J Biol Chem1983https://conductscience.org/library/papers/6355099PubMed
34,391,281Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.J Immunol1969https://conductscience.org/library/papers/4391281PubMed
44,396,488
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.
Immunology1971https://conductscience.org/library/papers/4396488PubMed
54,396,489Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.Immunology1971https://conductscience.org/library/papers/4396489PubMed
64,398,381Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.J Immunol1971https://conductscience.org/library/papers/4398381PubMed
74,145,387Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.J Exp Med1973https://conductscience.org/library/papers/4145387PubMed
84,149,590Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.J Immunol1974https://conductscience.org/library/papers/4149590PubMed
94,857,626Application of transformations to normalize the distribution of plaque-forming cells.J Immunol1974https://conductscience.org/library/papers/4857626PubMed
103,604Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells.J Immunol1976https://conductscience.org/library/papers/3604PubMed
11789,096A plaque assay for all cells secreting Ig of a given type or class.Eur J Immunol1976https://conductscience.org/library/papers/789096PubMed
126,973,183Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.Rev Infect Dis1981https://conductscience.org/library/papers/6973183PubMed
136,173,416Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.J Immunol1982https://conductscience.org/library/papers/6173416PubMed
146,749,846Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium.J Biol Chem1982https://conductscience.org/library/papers/6749846PubMed
156,602,801Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023.J Bacteriol1983https://conductscience.org/library/papers/6602801PubMed
166,707,694Beneficial modification of the endotoxin molecule.J Biol Response Mod1984https://conductscience.org/library/papers/6707694PubMed
176,382,555Lipid A and immunotherapy.Rev Infect Dis1984https://conductscience.org/library/papers/6382555PubMed
186,333,338The structure of the polysaccharide moiety of Rhodopseudomonas sphaeroides ATCC 17023 lipopolysaccharide.Eur J Biochem1984https://conductscience.org/library/papers/6333338PubMed
193,895,437Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.Science1985https://conductscience.org/library/papers/3895437PubMed
203,010,124Cachectin and tumour necrosis factor as two sides of the same biological coin.Nature1986https://conductscience.org/library/papers/3010124PubMed

See all 38 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
37,898,909TLR4 antagonism provides short-term but not long-term clinical benefit in a full-depth cartilage defect mouse model.Connect Tissue Res2024https://conductscience.org/library/papers/37898909PubMed
34,859,107Gender Variations in the Oral Microbiomes of Elderly Patients with Initial Periodontitis.J Immunol Res2021https://conductscience.org/library/papers/34859107PubMed
31,417,543Pellino-1 Regulates Immune Responses to Haemophilus influenzae in Models of Inflammatory Lung Disease.Front Immunol2019https://conductscience.org/library/papers/31417543PubMed
26,162,692TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.Immunobiology2015https://conductscience.org/library/papers/26162692PubMed
20,665,202Lipid A-mediated tolerance and cancer therapy.Adv Exp Med Biol2010https://conductscience.org/library/papers/20665202PubMed
14,711,650Characterization of lipopolysaccharides present in settled house dust.Appl Environ Microbiol2004https://conductscience.org/library/papers/14711650PubMed
9,529,058Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A.Infect Immun1998https://conductscience.org/library/papers/9529058PubMed
2,228,218Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.Infect Immun1990https://conductscience.org/library/papers/2228218PubMed
1,937,775Splenic T-lymphocyte functions during early syphilitic infection are complex.Infect Immun1991https://conductscience.org/library/papers/1937775PubMed
1,831,794Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A.Infect Immun1991https://conductscience.org/library/papers/1831794PubMed
1,828,058Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice.Infect Immun1991https://conductscience.org/library/papers/1828058PubMed
1,535,339Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.Infect Immun1992https://conductscience.org/library/papers/1535339PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2143752

GET https://conductscience.org/api/papers/v1/2143752/references?page=2